Potential implications for the prevention of postmenopausal osteoporosis after premature discontinuation of the estrogen and progestin arm of the womens health initiative (WHI)

被引：0
|
作者：
Dören, M [1 ]
Scheidt-Nave, C [1 ]
Baum, E [1 ]
Minne, H [1 ]
Pfeilschifter, J [1 ]
机构：
[1] Free Univ Berlin, Benjamin Franklin Hosp, Clin Res Ctr, Berlin, Germany
来源：
OSTEOPOROSIS INTERNATIONAL | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O25
引用
收藏
页码：S18 / S19
页数：2
相关论文
共 7 条
  • [1] Fracture risk after estrogen plus progestin discontinuation: The women's health initiative.
    Jackson, RD
    Watts, NB
    Caralis, P
    Cauley, JA
    Chen, Z
    Greep, N
    LaCroix, AZ
    Lewis, CE
    Mouton, CP
    Neuner, JM
    O'Sullivan, MJ
    Robbins, JA
    Sato, A
    Stefanick, ML
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S27 - S27
  • [2] Estrogen/progestin (E+P) therapy and gallbladder outcomes in postmenopausal sal women: The women's health initiative (WHI)
    Cirillo, D
    Wallace, R
    Rodabough, R
    Greenland, P
    LaCroix, A
    Limacher, M
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (11) : S99 - S99
  • [3] Issues to debate on the Women's Health Initiative (WHI) study. Prescription attitudes among Belgian gynaecologists after premature discontinuation of the WHI study
    Ena, G
    Rozenberg, S
    HUMAN REPRODUCTION, 2003, 18 (11) : 2245 - 2248
  • [4] Breast cancer after stopping estrogen plus progestin in postmenopausal women in the women's health initiative.
    Chlebowski, R. T.
    Kuller, L.
    Anderson, G.
    Mason, J. A.
    Schenken, R.
    Rajkovic, A.
    Stefanick, M.
    Sarto, G.
    Ravdin, P.
    Prentice, R.
    CANCER RESEARCH, 2009, 69 (02) : 78S - 79S
  • [5] The effects of estrogen plus progestin, on bone mineral density (BMD) in postmenopausal women of different ages and ethnic groups enrolled in the Women's Health Initiative (WHI).
    LeBoff, MS
    Cauley, J
    Chen, Z
    LaCroix, A
    Pettinger, M
    Cummings, S
    Watts, NB
    Lewis, C
    McGowan, J
    Stefanick, M
    Wactawski-Wende, J
    Robbins, J
    Jackson, R
    Neuner, J
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S94 - S94
  • [6] Breast cancer incidence and hormone therapy use before and after the Women's Health Initiative (WHI) estrogen (E) plus progestin (P) trial by race/ethnicity
    Chlebowski, Rowan T.
    Aragaki, Aaron K.
    Anderson, Garnet L.
    Prentice, Ross L.
    CANCER RESEARCH, 2019, 79 (13)
  • [7] Increased Risk of Hip Fractures in Postmenopausal Women with Moderate-Severe Pelvic Organ Prolapse: Analysis of Data from the Women's Health Initiative Estrogen Plus Progestin (WHI E Plus P) Trial
    Pal, Lubna
    Hailpern, Susan M.
    Santoro, Nanette F.
    Freeman, Ruth
    Barad, David
    Kipersztok, Simon
    Barnabei, Vanessa M.
    Wassertheil-Smoller, Sylvia
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1205 - 1205
1